dementia drugs
-
Oct- 2024 -21 OctoberTechnology
Dementia drug rejected by TGA
The Therapeutic Goods Administration (TGA) has decided not to register Alzheimer's drug lecanemab (LEQEMBI) on the basis that "the demonstrated…
The Therapeutic Goods Administration (TGA) has decided not to register Alzheimer's drug lecanemab (LEQEMBI) on the basis that "the demonstrated…